Home › Research › Long-term cohort studies
Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimer’s disease
Li XC, Finney CA, Shvetcov A.. bioRxiv, 2026-09-03
Topic: Genetics and APOE
Plain-language summary
The apolipoprotein E ε4 ( APOE ε4) allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD), yet its associated protein changes across biofluids, brain regions, and cell types remain incompletely understood. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimer’s Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). To characterise APOE ε4 effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and patient induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. In plasma, APOE ε4 carriers shared a proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this plasma signature discriminated carriers from non-carriers in an independent CSF cohort, and mediation analysis resolved a subset of these proteins into those lying upstream and downstream of AD. Carriage was also associated with greater neuropathological burden, reflected in higher Braak stages and CERAD scores. However, only limited APOE ε4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor concordance between the transcriptome and proteome. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE ε4-associated changes. These findings show that APOE ε4 is associated with a consistent proteomic signature across plasma and CSF, but its effects in the brain differ across cell types and brain regions.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Li, X. C., Finney, C. A., & Shvetcov, A. (2026). Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimer’s disease. bioRxiv. https://doi.org/10.64898/2026.08.27.746928
Vancouver
Li XC, Finney CA, Shvetcov A. Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimer’s disease. bioRxiv. 2026. doi:10.64898/2026.08.27.746928.
BibTeX
@article{li2026-04732701,
author = {Li, X. C. and Finney, C. A. and Shvetcov, A.},
title = {{Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimer’s disease}},
journal = {bioRxiv},
year = {2026},
doi = {10.64898/2026.08.27.746928},
url = {https://doi.org/10.64898/2026.08.27.746928}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Carriage was also associated with greater neuropathological burden, reflected in higher Braak stages and CERAD scores.
- Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE ε4-associated changes.
- These findings show that APOE ε4 is associated with a consistent proteomic signature across plasma and CSF, but its effects in the brain differ across cell types and brain regions.
Study details
- Participants1,691
- Evidence strengthModerate
How this study scored 16/100
Preprint — not yet peer-reviewed. It scored 34 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for study design, effect reported and randomized / blinded because the record does not state it. We have no data on times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 21 of the 62 points we could judge it on, which is 34 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 2 / 10 | Tier 4 — not a peer-reviewed journal (bioRxiv) |
| Journal's citation record | 0 / 4 | Not a journal article, so the journal's record does not count |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 4 / 10 | Preprint — not yet peer-reviewed. Hosted on a preprint server. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 3 / 4 | 1,691 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 21 / 62 | Scored on 12 of 20 parts. We have no data for the rest, so they are left out: 21 of the 62 points we could judge it on is 34 out of 100. |
| Total | 34 / 100 | Capped to 16 because this is not a peer-reviewed article. |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Long-term cohort studies from nearby years
Also tagged “apoe2”
265 studies in the library carry the topic tag “apoe2”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 265 tagged studies.